EMILIN2 and colorectal carcinoma: We verified that the expression of EMILIN-2 was variable among the CRC patients, thus we sought to evaluate the effects of EMILIN-2 loss in CRC development, also considering its role in modulating the Wnt/β-catenin signaling pathway [29].